Marieke van Son

81 FOCAL SALVAGE TREATMENT: A NARRATIVE REVIEW 67. Kass-Iliyya, A.; Jovic, G.; Murphy, C.; Fisher, C.; Syndikus, I.; Jose, C.; Scrase, C.D.; Graham, J.D.; Nicol, D.; Sydes, M.R., et al. Two-years postradiotherapy biop- sies: Lessons from mrc rt01 trial. Eur Urol 2018, 73, 968-976; DOI: 10.1016/j. eururo.2017.12.017. 68. Cornford, P.; Bellmunt, J.; Bolla, M.; Briers, E.; De Santis, M.; Gross, T.; Henry, A.M.; Joniau, S.; Lam, T.B.; Mason, M.D., et al. Eau-estro-siog guidelines on pros- tate cancer. Part ii: Treatment of relaps- ing, metastatic, and castration-resistant prostate cancer. Eur Urol 2017, 71, 630- 642; DOI: 10.1016/j.eururo.2016.08.002. 69. Kanthabalan, A.; Abd-Alazeez, M.; Arya, M.; Allen, C.; Freeman, A.; Jameson, C.; Kirkham, A.; Mitra, A.V.; Payne, H.; Pun- wani, S., et al. Transperineal magnetic resonance imaging-targeted biopsy versus transperineal template prostate mapping biopsy in the detection of lo- calized radio-recurrent prostate cancer. Clinical oncology (Royal College of Ra- diologists (Great Britain)) 2016, 28, 568- 576; DOI: 10.1016/j.clon.2016.04.038. 70. Crook, J.M.; Bahadur, Y.A.; Robertson, S.J.; Perry, G.A.; Esche, B.A. Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in se- quential prostate biopsies after external beam radiotherapy for patients with pros- tate carcinoma. Cancer 1997, 79, 81-89. 71. Goldstein, N.S.; Martinez, A.; Vicini, F.; Stromberg, J. The histology of radiation therapy effect on prostate adenocarci- noma as assessed by needle biopsy after brachytherapy boost. Correlation with biochemical failure. American journal of clinical pathology 1998, 110, 765-775. 72. Grignon, D.J.; Sakr, W.A. Histologic ef- fects of radiation therapy and total an- drogen blockade on prostate cancer. Cancer 1995, 75, 1837-1841. 73. de Castro Abreu, A.L.; Bahn, D.; Leslie, S.; Shoji, S.; Silverman, P.; Desai, M.M.; Gill, I.S.; Ukimura, O. Salvage focal and salvage total cryoablation for locally re- current prostate cancer after primary ra- diation therapy. BJU international 2013, 112, 298-307; DOI: 10.1111/bju.12151. 74. Kongnyuy, M.; Berg, C.J.; Kosinski, K.E.; Habibian, D.J.; Schiff, J.T.; Corcoran, A.T.; Katz, A.E. Salvage focal cryosurgery may delay use of androgen deprivation therapy in cryotherapy and radiation recurrent prostate cancer patients. In- ternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2017, 33, 810-813; DOI: 10.1080/02656736.2017.1306121. 75. Li, Y.H.; Elshafei, A.; Agarwal, G.; Ruckle, H.; Powsang, J.; Jones, J.S. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radio- therapy: Initial results from the cryo on- line data registry. The Prostate 2015, 75, 1-7; DOI: 10.1002/pros.22881. 76. Kanthabalan, A.; Peters, M.; Van Vulpen, M.; McCartan, N.; Hindley, R.G.; Emara, A.; Moore, C.M.; Arya, M.; Emberton, M.; Ahmed, H.U. Focal salvage high-intensi- ty focused ultrasound in radiorecurrent prostate cancer. BJU international 2017, 120, 246-256; DOI: 10.1111/bju.13831. 77. Kunogi, H.; Wakumoto, Y.; Yamaguchi, N.; Horie, S.; Sasai, K. Focal partial sal- vage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature. J Contemp Brachytherapy 2016, 8, 165-172; DOI: 10.5114/jcb.2016.60452. 78. Peters, M.; Maenhout, M.; van der Voort van Zyp, J.R.; Moerland, M.A.; Moman, M.R.; Steuten, L.M.; van Deursen, M.J.; van Vulpen, M. Focal salvage iodine- 125 brachytherapy for prostate cancer recurrences after primary radiotherapy: A retrospective study regarding toxicity, biochemical outcome and quality of life. Radiother Oncol 2014, 112, 77-82; DOI: 10.1016/j.radonc.2014.06.013. 4